Avio Smart Market Stack Limited (ASMS) has inked a shareholders agreement with Hyderabad-based Huwel Lifesciences, acquiring a minority stake and revenue-sharing rights. The collaboration leverages Huwel’s cost-efficient Quantiplex® TB testing platform, aiming to disrupt India’s ₹1,000 crore molecular diagnostics market with affordable, scalable solutions.
Avio Smart Market Stack Limited (ASMS), formerly known as Bartronics India, has announced a landmark shareholders agreement with Huwel Lifesciences, signaling a bold entry into India’s fast-growing molecular TB diagnostics market.
Key Highlights of the Deal:
-
Minority Stake Acquisition: ASMS secures equity in Huwel, strengthening its foothold in healthcare innovation.
-
Revenue-Sharing Rights: The agreement entitles ASMS to a defined share of net project revenues, ensuring long-term financial synergy.
-
Market Opportunity: India’s TB diagnostics market is valued at approximately ₹1,000 crore, offering immense growth potential.
-
Technology Edge: Huwel’s Quantiplex® platform delivers cost-effective TB testing at ₹340 per sample, nearly half the price of existing systems (₹700–₹1,000).
-
Infrastructure Compatibility: The solution integrates seamlessly with current RT-PCR setups, enabling rapid adoption across public health networks.
This strategic collaboration positions ASMS as a key player in tackling India’s TB burden, aligning with national health priorities while unlocking scalable business opportunities. By combining Huwel’s cutting-edge diagnostics with ASMS’s market expertise, the partnership is set to redefine accessibility and affordability in critical healthcare.
Sources: BSE (Bombay Stock Exchange), ScanX News, Business Standard